Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study

No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study

(2019) Daniel M. Jordan et al.   PLOS MEDICINE

MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank

(2018) Xue Li et al.   ANNALS OF THE RHEUMATIC DISEASES

Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank

(2017) Adrian Cortes et al.   NATURE GENETICS

Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies

(2017) Xue Li et al.   BMJ-British Medical Journal

Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies

(2017) Xue Li et al.   BMJ-British Medical Journal

2016 update of the EULAR recommendations for the management of early arthritis

(2016) Bernard Combe et al.   ANNALS OF THE RHEUMATIC DISEASES

Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis

(2016) Jon White et al.   Lancet Diabetes & Endocrinology

Glucokinase regulatory protein

(2015) Anne Raimondo et al.   CURRENT OPINION IN LIPIDOLOGY

Serum uric acid and the risk of cardiovascular and renal disease

(2015) Claudio Borghi et al.   JOURNAL OF HYPERTENSION

Uric Acid and Cardiovascular Events: A Mendelian Randomization Study

(2015) M. E. Kleber et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Relationship between Hyperuricemia and Lipid Profiles in US Adults

(2015) Tao-Chun Peng et al.   Biomed Research International

Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies

(2014) Ji Wang et al.   PLoS One

Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function

(2013) A. Mazharian et al.   BLOOD

Metabolic syndrome, diabetes, and hyperuricemia

(2013) Changgui Li et al.   CURRENT OPINION IN RHEUMATOLOGY

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data

(2013) Joshua C Denny et al.   NATURE BIOTECHNOLOGY

Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts

(2013) T. M. Palmer et al.   BMJ-British Medical Journal

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations

(2012) Anna Köttgen et al.   NATURE GENETICS

Association of rs780094 in GCKR with Metabolic Traits and Incident Diabetes and Cardiovascular Disease: The ARIC Study

(2010) Mark Bi et al.   PLoS One

Uric Acid and Hypertension: Cause or Effect?

(2010) Marilda Mazzali et al.   Current Rheumatology Reports

Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations

(2009) Melanie Kolz et al.   PLoS Genetics

Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension

(2008) Daniel I. Feig et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

(2008) Abbas Dehghan et al.   LANCET

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

(2008) Veronique Vitart et al.   NATURE GENETICS

Uric Acid and Cardiovascular Risk

(2008) Daniel I. Feig et al.   NEW ENGLAND JOURNAL OF MEDICINE